A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: data to inform clinical care and health policy
The aim of this systematic review and meta-analysis is to evaluate available prevalence and viral sequencing data representing chronic hepatitis B (CHB) infection in Kenya. More than 20% of the global disease burden from CHB is in Africa, however there is minimal high quality seroprevalence data fro...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Public Library of Science
2023
|
| _version_ | 1826310587470053376 |
|---|---|
| author | Downs, LO Campbell, C Yonga, P Githinji, G Ansari, MA Matthews, PC Etyang, AO |
| author_facet | Downs, LO Campbell, C Yonga, P Githinji, G Ansari, MA Matthews, PC Etyang, AO |
| author_sort | Downs, LO |
| collection | OXFORD |
| description | The aim of this systematic review and meta-analysis is to evaluate available prevalence and viral sequencing data representing chronic hepatitis B (CHB) infection in Kenya. More than 20% of the global disease burden from CHB is in Africa, however there is minimal high quality seroprevalence data from individual countries and little viral sequencing data available to represent the continent. We undertook a systematic review of the prevalence and genetic data available for hepatitis B virus (HBV) in Kenya using the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) 2020 checklist. We identified 23 studies reporting HBV prevalence and 8 studies that included HBV genetic data published in English between January 2000 and December 2021. We assessed study quality using the Joanna Briggs Institute critical appraisal checklist. Due to study heterogeneity, we divided the studies to represent low, moderate, high and very high-risk for HBV infection, identifying 8, 7, 5 and 3 studies in these groups, respectively. We calculated pooled HBV prevalence within each group and evaluated available sequencing data. Pooled HBV prevalence was 3.4% (95% CI 2.7-4.2%), 6.1% (95% CI 5.1-7.4%), 6.2% (95% CI 4.64-8.2) and 29.2% (95% CI 12.2-55.1), respectively. Study quality was overall low; only three studies detailed sample size calculation and 17/23 studies were cross sectional. Eight studies included genetic information on HBV, with two undertaking whole genome sequencing. Genotype A accounted for 92% of infections. Other genotypes included genotype D (6%), D/E recombinants (1%) or mixed populations (1%). Drug resistance mutations were reported by two studies. There is an urgent need for more high quality seroprevalence and genetic data to represent HBV in Kenya to underpin improved HBV screening, treatment and prevention in order to support progress towards elimination targets. |
| first_indexed | 2024-03-07T07:55:37Z |
| format | Journal article |
| id | oxford-uuid:2d7fd237-70de-40ac-bf48-040c1b7e168a |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:55:37Z |
| publishDate | 2023 |
| publisher | Public Library of Science |
| record_format | dspace |
| spelling | oxford-uuid:2d7fd237-70de-40ac-bf48-040c1b7e168a2023-08-16T16:11:44ZA systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: data to inform clinical care and health policyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:2d7fd237-70de-40ac-bf48-040c1b7e168aEnglishSymplectic ElementsPublic Library of Science2023Downs, LOCampbell, CYonga, PGithinji, GAnsari, MAMatthews, PCEtyang, AOThe aim of this systematic review and meta-analysis is to evaluate available prevalence and viral sequencing data representing chronic hepatitis B (CHB) infection in Kenya. More than 20% of the global disease burden from CHB is in Africa, however there is minimal high quality seroprevalence data from individual countries and little viral sequencing data available to represent the continent. We undertook a systematic review of the prevalence and genetic data available for hepatitis B virus (HBV) in Kenya using the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) 2020 checklist. We identified 23 studies reporting HBV prevalence and 8 studies that included HBV genetic data published in English between January 2000 and December 2021. We assessed study quality using the Joanna Briggs Institute critical appraisal checklist. Due to study heterogeneity, we divided the studies to represent low, moderate, high and very high-risk for HBV infection, identifying 8, 7, 5 and 3 studies in these groups, respectively. We calculated pooled HBV prevalence within each group and evaluated available sequencing data. Pooled HBV prevalence was 3.4% (95% CI 2.7-4.2%), 6.1% (95% CI 5.1-7.4%), 6.2% (95% CI 4.64-8.2) and 29.2% (95% CI 12.2-55.1), respectively. Study quality was overall low; only three studies detailed sample size calculation and 17/23 studies were cross sectional. Eight studies included genetic information on HBV, with two undertaking whole genome sequencing. Genotype A accounted for 92% of infections. Other genotypes included genotype D (6%), D/E recombinants (1%) or mixed populations (1%). Drug resistance mutations were reported by two studies. There is an urgent need for more high quality seroprevalence and genetic data to represent HBV in Kenya to underpin improved HBV screening, treatment and prevention in order to support progress towards elimination targets. |
| spellingShingle | Downs, LO Campbell, C Yonga, P Githinji, G Ansari, MA Matthews, PC Etyang, AO A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: data to inform clinical care and health policy |
| title | A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: data to inform clinical care and health policy |
| title_full | A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: data to inform clinical care and health policy |
| title_fullStr | A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: data to inform clinical care and health policy |
| title_full_unstemmed | A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: data to inform clinical care and health policy |
| title_short | A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: data to inform clinical care and health policy |
| title_sort | systematic review of hepatitis b virus hbv prevalence and genotypes in kenya data to inform clinical care and health policy |
| work_keys_str_mv | AT downslo asystematicreviewofhepatitisbvirushbvprevalenceandgenotypesinkenyadatatoinformclinicalcareandhealthpolicy AT campbellc asystematicreviewofhepatitisbvirushbvprevalenceandgenotypesinkenyadatatoinformclinicalcareandhealthpolicy AT yongap asystematicreviewofhepatitisbvirushbvprevalenceandgenotypesinkenyadatatoinformclinicalcareandhealthpolicy AT githinjig asystematicreviewofhepatitisbvirushbvprevalenceandgenotypesinkenyadatatoinformclinicalcareandhealthpolicy AT ansarima asystematicreviewofhepatitisbvirushbvprevalenceandgenotypesinkenyadatatoinformclinicalcareandhealthpolicy AT matthewspc asystematicreviewofhepatitisbvirushbvprevalenceandgenotypesinkenyadatatoinformclinicalcareandhealthpolicy AT etyangao asystematicreviewofhepatitisbvirushbvprevalenceandgenotypesinkenyadatatoinformclinicalcareandhealthpolicy AT downslo systematicreviewofhepatitisbvirushbvprevalenceandgenotypesinkenyadatatoinformclinicalcareandhealthpolicy AT campbellc systematicreviewofhepatitisbvirushbvprevalenceandgenotypesinkenyadatatoinformclinicalcareandhealthpolicy AT yongap systematicreviewofhepatitisbvirushbvprevalenceandgenotypesinkenyadatatoinformclinicalcareandhealthpolicy AT githinjig systematicreviewofhepatitisbvirushbvprevalenceandgenotypesinkenyadatatoinformclinicalcareandhealthpolicy AT ansarima systematicreviewofhepatitisbvirushbvprevalenceandgenotypesinkenyadatatoinformclinicalcareandhealthpolicy AT matthewspc systematicreviewofhepatitisbvirushbvprevalenceandgenotypesinkenyadatatoinformclinicalcareandhealthpolicy AT etyangao systematicreviewofhepatitisbvirushbvprevalenceandgenotypesinkenyadatatoinformclinicalcareandhealthpolicy |